Purchase Order DOCSB134115SU0579
Award Date 7/29/15
Potential Completion Date 9/17/20
Potential Value $141K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20899, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $90,997.20 firm fixed-price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract is for the supply of an MISEQ I100 PLUS SYSTEM, with a period of performance running through December 12, 2025. This contract was not set aside for any specific business type. Illumina holds several other federal Indefinite...
- This is a firm fixed-price purchase order awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for a service agreement to provide Illumina HiSeq and MiSeq equipment, with a ceiling value of $87,393.52 and a completion date of September 15, 2021. The contract does not have a set-aside designation. Illumina is a for-profit organization and...
- This is a $89,238.80 firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of an ILLUMINA MISEQ I100 PLUS SEQUENCER to replace an existing system in the NIEHS Epigenomics Core Laboratory. The contract has an ultimate completion date of September 9, 2026. Illumina, Inc. is a for-profit biotechnology company that specializes in genetic...
- This $95,931.00 firm fixed price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract is for the provision of a MiSeq System, a genetic analysis platform used in life science research, applied markets, and molecular diagnostics. Illumina has a history of providing sequencing systems and consumables to support...
- This is a $119,060.18 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of an MISEQ2 sequencing instrument and associated reagents. The contract has no set-aside designation. Illumina, a manufacturer of genetic analysis instruments and reagents, has been awarded multiple prior federal contracts and sub-grants to provide...
- This is a $95,931.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is for the purchase of an Illumina MiSeq2 sequencing system and associated components. Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, is the prime contractor. This contract does not have a set-aside designation. Illumina has provided...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of a MiSeq benchtop DNA sequencer system. The total ceiling value of the contract is $119,937.50, with a performance period ending on December 2, 2013. The contract does not have any set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions,...
- The Department of Commerce National Institute of Standards and Technology (NIST) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of two (2) Illumina DNA sequencing instruments that are compatible with the validated protocols developed by NIST, in accordance with the stated requirements. The potential value of the contract is $100,878.00, and it was...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the purchase of a MiSeq System sequencing platform. The contract has a ceiling value of $95,931.00 and a completion date of August 21, 2014. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously provided such products and services to various federal...
- This $95,931 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq High Throughput Sequencer System. The award did not have a set-aside designation. The MiSeq system will be used in NIAID's Laboratory of Immunoregulation and must be fully compatible with Illumina's existing on-site software, kits, and reagents. Illumina has a history of providing...